Taratula and collaborators including OSU postdoctoral researcher Babak Mamnoon and Maureen Baldwin, a physician at Oregon ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.

Choriocarcinoma is caused by abnormal tissue that develops after sperm fertilizes an egg inside the womb. Anyone with a uterus can develop this type of tumor, and there are certain risk factors to ...

Findings of the study into choriocarcinoma, which occurs in the United States at a rate of about four cases per 100,000 pregnancies, were published in Small Science. Typically starting in the ...

Scientists have found a way to combat a rare, aggressive form of cancer affecting pregnant women and to better ensure the drug used for the disease reaches tumor cells without damaging healthy tissue.

The seminoma had a favorable prognosis. A high rate of death was noted in those with embryonal-cell carcinoma and choriocarcinoma (Table 1). The presence of teratoma in mixed tumors appeared to ...